Barnett & Company, Inc. Abb Vie Inc. Transaction History

Barnett & Company, Inc.

$143 Million
Q3 2024

A detailed history of Barnett & Company, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Barnett & Company, Inc. holds 33,468 shares of ABBV stock, worth $6.02 Million. This represents 4.63% of its overall portfolio holdings.

Number of Shares

33,468

Previous 33,668 0.59%

Holding current value

$6.02 Million

Previous $5.77 Million 14.46%

% of portfolio

4.63%

Previous 4.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $32,768 - $39,866	-200 Reduced 0.59%	33,468 $6.61 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $39,955 - $45,525	-250 Reduced 0.74%	33,668 $6.13 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $247,680 - $278,946	-1,800 Reduced 5.04%	33,918 $5.26 Million
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $362,830 - $420,029	-2,716 Reduced 7.07%	35,718 $5.32 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $105,345 - $131,095	-795 Reduced 2.03%	38,434 $5.18 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $37,598 - $43,300	260 Added 0.67%	39,229 $6.25 Million
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $48,408 - $58,054	350 Added 0.91%	38,969 $0
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $104,952 - $120,373	-782 Reduced 1.98%	38,619 $5.18 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $21,743 - $27,643	158 Added 0.4%	39,401 $6.04 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $10,162 - $12,608	-77 Reduced 0.2%	39,243 $6.36 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $24,601 - $31,127	-229 Reduced 0.58%	39,320 $5.32 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $93,632 - $106,286	-880 Reduced 2.18%	39,549 $4.27 Million
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $265,023 - $295,251	2,519 Added 6.64%	40,429 $4.55 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $954,765 - $1.05 Million	9,333 Added 32.66%	37,910 $4.1 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $108,259 - $146,161	1,345 Added 4.94%	28,577 $3.06 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $223,366 - $262,158	2,600 Added 10.56%	27,232 $2.39 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $1.8 Million - $2.41 Million	24,532 Added 24532.0%	24,632 $2.42 Million
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $7,714 - $9,079	100 New	100 $8,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $25,762 - $34,498	-280 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $19,703 - $21,606	-220 Reduced 44.0%	280 $27,000
Q3 2017 Nov 20, 2017	BUY	$69.85 - $89.22 $34,925 - $44,610	500	500 $44,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barnett & Company, Inc. with notifications on news.

Account

Barnett & Company, Inc. Abb Vie Inc. Transaction History